Stay updated on PEGylated Hyaluronidase Clinical Trial
Sign up to get notified when there's something new on the PEGylated Hyaluronidase Clinical Trial page.

Latest updates to the PEGylated Hyaluronidase Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study on PEGylated Recombinant Human Hyaluronidase for pancreatic ductal adenocarcinoma, including study purpose, participant criteria, and exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference18%
- Check48 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check56 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check92 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check106 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, potentially impacting performance and availability.SummaryDifference0.6%
Stay in the know with updates to PEGylated Hyaluronidase Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGylated Hyaluronidase Clinical Trial page.